Literature DB >> 21524638

Racial disparities in cardiovascular risk factors among diagnosed hypertensive subjects.

Xuefeng Liu1, Meng Liu, Dennis Tsilimingras, Ernesto L Schiffrin.   

Abstract

Racial disparities in cardiovascular disease (CVD) have become a matter of national concern. We investigated racial disparities and trends in glycosylated hemoglobin, high-density lipoprotein (HDL), C-reactive protein, plasma homocysteine, albuminuria, and other risk factors among 4758 diagnosed hypertensive subjects age 18 years or older from the National Health and Nutrition Examination Survey, 1999-2006. Compared with non-Hispanic whites, Hispanics, and non-Hispanic blacks were more likely to have uncontrolled blood pressure (BP) (Hispanics odds ratio [OR]: 1.58, 95% confidence interval [CI]: 1.21-2.07; blacks OR: 1.42, 95% CI: 0.21-1.67), elevated glycosylated hemoglobin (Hispanics OR: 2.70, 95% CI: 1.89-3.87; blacks OR: 2.17, 95% CI: 1.70-2.77), albuminuria (Hispanics OR: 2.36, 95% CI: 1.71-3.27; blacks OR: 1.80, 95% CI: 1.47-2.20), and less likely to have central obesity (Hispanics OR: 0.68, 95% CI: 0.51-0.91; blacks OR: 0.70, 95% CI: 0.58-0.84). Blacks had lower risks of elevated serum cholesterol (OR: 0.81, 95% CI: 0.67-0.98) and low HDL (OR: 0.76, 95% CI: 0.61-0.94) than whites. The risk of high serum homocysteine was lower in Hispanics and higher in blacks compared with whites (Hispanics OR: 0.64, 95% CI: 0.46-0.90; blacks OR: 1.36, 95% CI: 1.14-1.63). These results highlight the need for targeted interventions to aggressively treat uncontrolled BP, elevated glycosylated hemoglobin in Hispanic and black hypertensive subjects, and high serum homocysteine in blacks, to reduce disparities in CVD risk factors and CVD-associated morbidity and mortality. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524638     DOI: 10.1016/j.jash.2011.03.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  8 in total

1.  Health care utilization and hypertension management in community-based elderly Korean immigrants.

Authors:  Mo-Kyung Sin; Anne Hirsch
Journal:  J Immigr Minor Health       Date:  2013-12

2.  A Cardiovascular Health Intervention for Spanish Speakers: The Health Literacy and ESL Curriculum.

Authors:  Francisco Soto Mas; Cheryl L Schmitt; Holly E Jacobson; Orrin B Myers
Journal:  J Community Health       Date:  2018-08

Review 3.  Hypertension and overweight/obesity in Ghanaians and Nigerians living in West Africa and industrialized countries: a systematic review.

Authors:  Yvonne Commodore-Mensah; Laura J Samuel; Cheryl R Dennison-Himmelfarb; Charles Agyemang
Journal:  J Hypertens       Date:  2014-03       Impact factor: 4.844

Review 4.  Obesity Epidemiology Worldwide.

Authors:  Cassandra Arroyo-Johnson; Krista D Mincey
Journal:  Gastroenterol Clin North Am       Date:  2016-12       Impact factor: 3.806

5.  Prevalence and trends of isolated systolic hypertension among untreated adults in the United States.

Authors:  Xuefeng Liu; Carlos J Rodriguez; Kesheng Wang
Journal:  J Am Soc Hypertens       Date:  2015-01-13

6.  Untreated Isolated Sytolic Hypertension among Middle-Aged and Old Adults in the United States: Trends in the Prevalence by Demographic Factors During 1999-2010.

Authors:  Xuefeng Liu; Van Minh Hoang; Yali Liu; Rachel L W Brown
Journal:  Int J Chronic Dis       Date:  2015-02-23

7.  Association between Health Literacy and Prevalence of Obesity, Arterial Hypertension, and Diabetes Mellitus.

Authors:  Božica Lovrić; Harolt Placento; Nikolina Farčić; Metka Lipič Baligač; Štefica Mikšić; Marin Mamić; Tihomir Jovanović; Hrvoje Vidić; Sandra Karabatić; Sabina Cviljević; Lada Zibar; Ivan Vukoja; Ivana Barać
Journal:  Int J Environ Res Public Health       Date:  2022-07-24       Impact factor: 4.614

8.  Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy.

Authors:  Shawna Nesbitt; Ali Shojaee; Jen-Fue Maa
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.